Nantahala Capital Management’s Cue Biopharma CUE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-890	Closed	-$50.4K	–	136
2024 Q1	$50.4K	Hold	890	–	–	﹤0.01%	119
2023 Q4	$70.5K	Sell	890 -2	-0.2%	-$143	0.01%	124
2023 Q3	$61.5K	Hold	892	–	–	0.01%	128
2023 Q2	$97.7K	Sell	892 -2,218	-71%	-$261K	0.01%	116
2023 Q1	$333K	Hold	3,110	–	–	0.03%	111
2022 Q4	$266K	Hold	3,110	–	–	0.02%	105
2022 Q3	$208K	Sell	3,110 -239	-7%	-$20.6K	0.02%	106
2022 Q2	$250K	Sell	3,349 -71,463	-96%	-$8.36M	0.02%	111
2022 Q1	$11M	Sell	74,812 -9,845	-12%	-$2.09M	0.76%	40
2021 Q4	$28.7M	Sell	84,657 -1,046	-1%	-$405K	1.79%	29
2021 Q3	$37.5M	Sell	85,703 -3,553	-4%	-$1.24M	2.21%	25
2021 Q2	$31.2M	Sell	89,256 -877	-1%	-$340K	1.72%	27
2021 Q1	$33M	Buy	90,133 +6,574	+8%	+$2.71M	1.88%	28
2020 Q4	$31.4M	Buy	83,559 +5,485	+7%	+$2.19M	1.62%	26
2020 Q3	$35.3M	Buy	78,074 +561	+0.7%	+$323K	2.35%	19
2020 Q2	$57M	Sell	77,513 -5,948	-7%	-$4.31M	3.68%	12
2020 Q1	$35.5M	Buy	83,461 +36,630	+78%	+$17.8M	2.91%	19
2019 Q4	$22.3M	Buy	46,831 +891	+2%	+$280K	1.48%	36
2019 Q3	$11.6M	Hold	45,940	–	–	0.85%	47
2019 Q2	$12.4M	Buy	45,940 +16,670	+57%	+$4.15M	0.73%	52
2019 Q1	$6.79M	Hold	29,270	–	–	0.45%	64
2018 Q4	$4.13M	Buy	29,270 +833	+3%	+$151K	0.31%	82
2018 Q3	$7.72M	Buy	28,437 +14,318	+101%	+$4.14M	0.51%	63
2018 Q2	$5.02M	Buy	+14,119	New	+$5.61M	0.39%	67